Every 8-K that BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow BTSGU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BTSGU filings page.
BrightSpring Health Services reported strong results for the quarter ended June 30, 2026. Total revenues were $3,873,140 (in thousands), up from $3,147,698, and gross profit rose to $492,746 (in thousands). Operating income increased to $130,391 (in thousands), with income from continuing operations of $86,604 (in thousands) and diluted EPS of $0.38 versus $0.13 a year earlier.
Adjusted EBITDA reached $205,505 (in thousands), compared with $142,517, supported by both segments. In Pharmacy Solutions, prescriptions were stable while revenue per script increased to $314.20 from $257.11 and gross profit per script to $27.50 from $21.54. Provider Services’ home health care average daily census grew to 46,448 from 30,085.
The company increased full-year 2026 guidance to revenues of $15,100 million to $15,425 million and total Adjusted EBITDA of $820 million to $845 million, excluding the Community Living business. Management expects the Amedisys and LHC branches acquisition to contribute about $35 million of Adjusted EBITDA in 2026.
BrightSpring Health Services, Inc. expanded its board of directors from seven to eight members and appointed Dr. Nigam H. Shah as a Class III director on June 11, 2026. He will also serve on the Board’s Quality and Compliance Committee and be compensated under the company’s standard non-employee director policy.
BrightSpring plans to enter into an indemnification agreement with Dr. Shah in the same form used for its other directors and states there are no related-party transactions requiring disclosure. A press release dated June 12, 2026, describing his appointment is furnished as Exhibit 99.1. The company highlights its nationwide home- and community-based pharmacy and health services, serving over 475,000 individuals daily across all 50 states.
BrightSpring Health Services, Inc. entered into an underwriting agreement for an underwritten secondary offering of 14,999,771 shares of its common stock at a public offering price of $58.75 per share. All of these shares were sold by existing selling stockholders, so the company itself did not receive offering proceeds.
In connection with the transaction, BrightSpring repurchased 1,026,465 shares of its common stock from the underwriter as part of the same offering, and the underwriter did not earn underwriting fees on the repurchased shares. The deal was executed under an automatic shelf registration statement on Form S-3ASR and supported by customary representations, covenants, and indemnification obligations among the company, the selling stockholders, and the underwriter.
BrightSpring Health Services, Inc. held its 2026 Annual Meeting of Stockholders, where holders of common stock had one vote per share as of the March 30, 2026 record date. A total of 186,457,085.30 shares were present or represented by proxy, about 96.53% of the voting power.
Stockholders elected three Class II directors, Olivia Kirtley, Max Lin and Steve Miller, to terms expiring at the 2029 annual meeting. They also ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the advisory, non-binding compensation vote for executive officers.
BrightSpring Health Services completed the previously announced sale of its Community Living business, including community living services, waiver programs, and intermediate care facilities, to Sevita for aggregate cash consideration of $835 million, subject to customary working capital and other adjustments. A BrightSpring subsidiary, Res-Care, transferred the related assets, equity interests, and liabilities under a purchase agreement signed in January 2025 and amended in December 2025.
BrightSpring’s unaudited pro forma statements show the sale as if it occurred on December 31, 2025, and include an expected $425 million repayment of first lien term loan debt. The estimated after-tax gain on the sale is $31.978 million, with a modest reduction in annual interest expense. Following closing, Robert Barnes, President of ResCare Community Living, resigned and received accelerated vesting of 15,540 restricted stock units and 5,640 stock options; his departure was not due to any disagreement with the company.
BrightSpring Health Services entered an underwriting agreement for an underwritten secondary offering of 20,000,000 shares of common stock at $41.15 per share. All of these shares were sold by KKR and management selling stockholders, so BrightSpring itself did not receive the sale proceeds, other than cash from related stock option exercises.
As part of the same transaction, BrightSpring repurchased 1,464,807 shares of its common stock from the underwriter. The underwriter did not receive underwriting fees on the repurchased shares. The deal was conducted under an automatic shelf registration on Form S-3ASR, with customary representations, covenants, and indemnification provisions.